CLINICAL_TRIALS
trial_result
· 2021-03-19
Clinical Trial Update: Brivanib Metastatic Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial update for brivanib in metastatic renal cell carcinoma; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Renal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-03-19